Works matching IS 00099236 AND DT 2024 AND VI 116 AND IP 5
Results: 26
Real‐World Evidence in Regulatory Decision Making: Time for Evidence Integration.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1153, doi. 10.1002/cpt.3444
- By:
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1158, doi. 10.1002/cpt.3437
- Publication type:
- Article
HIGHLIGHTED ARTICLES.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1156, doi. 10.1002/cpt.3435
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1151, doi. 10.1002/cpt.3434
- Publication type:
- Article
Item Response Theory Quantifies the Relationship Between Improvements in Serum Phosphate and Patient‐Reported Outcomes in Adults With X‐Linked Hypophosphatemia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1343, doi. 10.1002/cpt.3406
- By:
- Publication type:
- Article
Coproporphyrin‐I as a Selective OATP1B Biomarker Can Be Used to Delineate the Mechanisms of Complex Drug–Drug Interactions: Cedirogant Case Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1334, doi. 10.1002/cpt.3399
- By:
- Publication type:
- Article
Exposure Matching‐Based Pediatric Dose Selection for Drugs with Renal Excretion – Lessons Learned from Pediatric Development of Direct Oral Anticoagulants.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1174, doi. 10.1002/cpt.3396
- By:
- Publication type:
- Article
The Effect of Low‐Dose Colchicine on the Phenotype and Function of Neutrophils and Monocytes in Patients with Chronic Coronary Artery Disease: A Double‐Blind Randomized Placebo‐Controlled Cross‐Over Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1325, doi. 10.1002/cpt.3394
- By:
- Publication type:
- Article
Congenital and Fetal Effects After Mifepristone Exposure and Continuation of Pregnancy: A Systematic Review.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1207, doi. 10.1002/cpt.3392
- By:
- Publication type:
- Article
A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)‐Hydroxynorketamine in Healthy Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1314, doi. 10.1002/cpt.3391
- By:
- Publication type:
- Article
A Comparative Clinical Pharmacology Analysis of FDA‐Approved Targeted Covalent Inhibitors vs. Reversible Inhibitors in Oncology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1198, doi. 10.1002/cpt.3390
- By:
- Publication type:
- Article
Return to SENDer: The Submitted Electronic Data for Nonclinical Cardiovascular Studies is Not Facilitating Transparency, Translation or Innovation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1164, doi. 10.1002/cpt.3389
- By:
- Publication type:
- Article
Evaluating the Effect of Estimating Renal Function With the CKD‐EPI 2021 Equation on the ABCD‐GENE Score for Clopidogrel Response Prediction.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1227, doi. 10.1002/cpt.3385
- By:
- Publication type:
- Article
Ticagrelor modestly raises plasma riboflavin concentration in humans and inhibits riboflavin transport by BCRP and MRP4.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1222, doi. 10.1002/cpt.3384
- By:
- Publication type:
- Article
Population Pharmacokinetic Modeling and Exposure–Response Analysis for the Antibody–Drug Conjugate Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Carcinoma.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1278, doi. 10.1002/cpt.3383
- By:
- Publication type:
- Article
Cannabidiol Increases Psychotropic Effects and Plasma Concentrations of Δ<sup>9</sup>‐Tetrahydrocannabinol Without Improving Its Analgesic Properties.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1289, doi. 10.1002/cpt.3381
- By:
- Publication type:
- Article
Solanidine Metabolites as Diet‐Derived Biomarkers of CYP2D6‐Mediated Tamoxifen Metabolism in Breast Cancer Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1269, doi. 10.1002/cpt.3380
- By:
- Publication type:
- Article
Disentangling Anti‐Tumor Response of Immunotherapy Combinations: A Physiologically Based Framework for V937 Oncolytic Virus and Pembrolizumab.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1304, doi. 10.1002/cpt.3379
- By:
- Publication type:
- Article
Pseudo‐Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPC.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1259, doi. 10.1002/cpt.3374
- By:
- Publication type:
- Article
Limitations Reported in Evaluating Effectiveness of Risk Minimization Measures in the EU during 2018–2021: A Qualitative Analysis of Industry‐Sponsored Post‐Authorization Safety Studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1252, doi. 10.1002/cpt.3369
- By:
- Publication type:
- Article
Enhancing External Control Arm Analyses through Data Calibration and Hybrid Designs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1168, doi. 10.1002/cpt.3364
- By:
- Publication type:
- Article
Pharmacokinetics and Exposure–Response Analyses to Support Dose Selection of Upadacitinib in Crohn's Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1240, doi. 10.1002/cpt.3359
- By:
- Publication type:
- Article
Real‐World Evidence to Support EU Regulatory Decision Making—Results From a Pilot of Regulatory Use Cases.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1188, doi. 10.1002/cpt.3355
- By:
- Publication type:
- Article
Low Nirmatrelvir and Ritonavir Exposure through Breastmilk: Analyzing Milk Concentrations and Infant Risk.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1217, doi. 10.1002/cpt.3352
- By:
- Publication type:
- Article
Pharmacokinetics, Mass Balance, Safety, and Tolerability of Obeldesivir in Healthy Participants.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1231, doi. 10.1002/cpt.3337
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1143, doi. 10.1002/cpt.2948
- Publication type:
- Article